News
-
-
PRESS RELEASE
Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes
Onco-Innovations subsidiary Inka Health authors significant study on global transportability of clinical trial outcomes to real-world lung cancer populations, published in medRxiv -
-
PRESS RELEASE
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
Onco-Innovations partners with University of Alberta and Cross Cancer Institute for preclinical study focusing on hard-to-treat cancers, starting with glioblastoma. Research led by Dr. Michael Weinfeld -
-
-
-
PRESS RELEASE
Onco-Innovations Announces Start of Manufacturing of Preclinical Testing Material for Its PNKP Inhibitor Technology by Dalton Pharma
Onco-Innovations announces commencement of manufacturing for preclinical testing of nanoparticle-formulated PNKP inhibitor technology in collaboration with Dalton Pharma Services -
-
